Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

PROQR THERAPEUTICS ($PRQR) Releases Q3 2026 Earnings, Stock Rises

None

PROQR THERAPEUTICS ($PRQR) posted quarterly earnings results for Q3 2026 on Thursday, November 12th. The company reported earnings of -$0.09 per share, beating estimates of -$0.10 by $0.01. The company also reported revenue of $5,155,000, beating estimates of $4,508,124 by $646,876.

Stock price change since market open this morning: +6.73%

You can see Quiver Quantitative's $PRQR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive PRQR Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

PROQR THERAPEUTICS Insider Trading Activity

PRQR Insider Trades

PROQR THERAPEUTICS insiders have traded $PRQR stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $PRQR stock by insiders over the last 6 months:

  • BOER DANIEL ANTON DE (Chief Executive Officer) has made 2 purchases buying 300,000 shares for an estimated $499,500 and 0 sales.
  • BART FILIUS has made 2 purchases buying 300,000 shares for an estimated $488,925 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

PROQR THERAPEUTICS Hedge Fund Activity

We have seen 38 institutional investors add shares of PROQR THERAPEUTICS stock to their portfolio, and 19 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

PROQR THERAPEUTICS Price Targets

Multiple analysts have issued price targets for $PRQR recently. We have seen 3 analysts offer price targets for $PRQR in the last 6 months, with a median target of $6.0.

Here are some recent targets:

  • Gavin Clark-Gartner from Evercore ISI Group set a target price of $6.0 on 06/29/2026
  • Keay Nakae from Chardan Capital set a target price of $3.0 on 06/26/2026
  • Catherine Novack from Jones Trading set a target price of $10.0 on 06/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles